Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04699305 · ClinicalTrials.gov registry record
Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers
A clinical trial of Cutaneous Wounds, sponsored by RedDress.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04699305 is a study of Cutaneous Wounds that is actively recruiting participants, run by RedDress. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04699305, a study of Cutaneous Wounds, is actively recruiting participants, sponsored by RedDress.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Multicenter observational study to explore the efficacy of ActiGraft in the treatment of exuding cutaneous wounds in real-life usage.
Conditions Studied
Interventions
- DEVICE ActiGraft
Study Locations (1)
Nevada
- Wound Care Experts - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2019-02-14 |
| Est. Completion | 2027-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04699305
The ClinicalTrials.gov registry entry for NCT04699305 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RedDress, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cutaneous Wounds appearing as the primary indexed condition, and to 1 intervention - of which ActiGraft is the first listed.
NCT04699305 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.
Frequently Asked Questions
What is clinical trial NCT04699305 about?
NCT04699305 is a clinical study titled "Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers". Multicenter observational study to explore the efficacy of ActiGraft in the treatment of exuding cutaneous wounds in real-life usage.
What is the current status of trial NCT04699305?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2019-02-14. Estimated completion is 2027-01-31.
What conditions does trial NCT04699305 study?
This clinical trial studies the following conditions: Cutaneous Wounds.
What interventions are being tested in trial NCT04699305?
The interventions under investigation include: ActiGraft (DEVICE).
Who is sponsoring clinical trial NCT04699305?
This trial is sponsored by RedDress, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04699305 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.